Beelen, K., Hoefnagel, L. D., Opdam, M., Wesseling, J., Sanders, J., Vincent, A. D., . . . Linn, S. C. (2014). PI3K/AKT/mTOR pathway activation in primary and corresponding metastatic breast tumors after adjuvant endocrine therapy. Int J Cancer.
Citação norma ChicagoBeelen, Karin, Laurien DC Hoefnagel, Mark Opdam, Jelle Wesseling, J. Sanders, Andrew D. Vincent, Paul J. van Diest, and Sabine C. Linn. "PI3K/AKT/mTOR Pathway Activation in Primary and Corresponding Metastatic Breast Tumors After Adjuvant Endocrine Therapy." Int J Cancer 2014.
Citação norma MLABeelen, Karin, et al. "PI3K/AKT/mTOR Pathway Activation in Primary and Corresponding Metastatic Breast Tumors After Adjuvant Endocrine Therapy." Int J Cancer 2014.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.